IRIS
POLONELLI, Luciano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.388
AS - Asia 15.073
EU - Europa 11.224
SA - Sud America 3.348
AF - Africa 872
Continente sconosciuto - Info sul continente non disponibili 181
OC - Oceania 10
Totale 49.096
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.694
SG - Singapore 5.743
CN - Cina 4.249
VN - Vietnam 2.649
BR - Brasile 2.617
UA - Ucraina 2.123
IE - Irlanda 1.815
DE - Germania 1.670
SE - Svezia 1.242
FI - Finlandia 1.189
IT - Italia 1.127
HK - Hong Kong 1.007
ZA - Sudafrica 630
FR - Francia 565
NL - Olanda 555
CA - Canada 459
AR - Argentina 283
RU - Federazione Russa 283
TR - Turchia 244
GB - Regno Unito 236
BD - Bangladesh 231
IN - India 176
EC - Ecuador 144
AT - Austria 134
IQ - Iraq 112
MX - Messico 103
ID - Indonesia 96
CO - Colombia 88
JP - Giappone 79
PK - Pakistan 63
VE - Venezuela 63
MA - Marocco 53
ES - Italia 51
PY - Paraguay 50
PH - Filippine 46
BE - Belgio 45
UZ - Uzbekistan 43
KE - Kenya 42
PL - Polonia 41
CL - Cile 38
TH - Thailandia 38
EG - Egitto 36
SA - Arabia Saudita 36
TN - Tunisia 30
TW - Taiwan 28
PE - Perù 24
AE - Emirati Arabi Uniti 23
UY - Uruguay 23
CR - Costa Rica 22
KR - Corea 22
NP - Nepal 22
IL - Israele 20
JM - Giamaica 20
JO - Giordania 19
AZ - Azerbaigian 18
CZ - Repubblica Ceca 15
EU - Europa 15
KZ - Kazakistan 15
LB - Libano 15
MY - Malesia 15
BG - Bulgaria 14
BO - Bolivia 13
DO - Repubblica Dominicana 13
LT - Lituania 13
PA - Panama 13
DZ - Algeria 12
HU - Ungheria 12
NI - Nicaragua 12
RO - Romania 12
TT - Trinidad e Tobago 12
HN - Honduras 11
AL - Albania 10
CI - Costa d'Avorio 9
ET - Etiopia 9
RS - Serbia 9
BY - Bielorussia 8
AU - Australia 7
BB - Barbados 7
BH - Bahrain 7
DK - Danimarca 7
EE - Estonia 7
OM - Oman 7
BA - Bosnia-Erzegovina 6
GT - Guatemala 6
HR - Croazia 6
KW - Kuwait 6
NG - Nigeria 6
PS - Palestinian Territory 6
AO - Angola 5
KG - Kirghizistan 5
LK - Sri Lanka 5
PR - Porto Rico 5
SY - Repubblica araba siriana 5
BW - Botswana 4
CG - Congo 4
CH - Svizzera 4
GA - Gabon 4
GE - Georgia 4
LU - Lussemburgo 4
MN - Mongolia 4
Totale 48.847
Salva come PNG Salva come JPEG
Città #
Singapore 2.276
Jacksonville 2.248
Dublin 1.811
Ashburn 1.597
San Jose 1.390
Chandler 1.158
Beijing 1.067
Council Bluffs 1.037
Hong Kong 961
Ho Chi Minh City 888
Dearborn 780
Santa Clara 740
Nanjing 647
Boardman 614
Johannesburg 582
Hanoi 581
Dallas 571
San Mateo 570
Princeton 508
Lauterbourg 441
Toronto 337
Des Moines 264
Ann Arbor 245
Bremen 243
Helsinki 221
Moscow 220
Wilmington 220
Los Angeles 216
São Paulo 213
Shenyang 191
New York 189
Izmir 184
Munich 182
Kunming 171
Nanchang 167
Hefei 162
Hebei 160
Parma 141
Buffalo 129
Shanghai 128
Vienna 125
Haiphong 107
Jinan 105
Düsseldorf 103
Grafing 101
Tianjin 93
Changsha 90
Da Nang 90
Jiaxing 74
Rio de Janeiro 74
Guangzhou 73
Fortaleza 70
Milan 68
Seattle 66
Brasília 64
Fremont 62
Houston 60
Quito 56
Rome 56
Woodbridge 54
Atlanta 53
Biên Hòa 50
Frankfurt am Main 47
Marseille 47
Curitiba 46
Tokyo 46
Brooklyn 44
Brussels 43
Hải Dương 43
Columbus 42
Turku 42
Porto Alegre 41
Baghdad 38
Orem 38
Norwalk 37
Tashkent 37
Can Tho 36
Salvador 36
Nairobi 35
Hangzhou 34
Belo Horizonte 33
Montreal 33
North Bergen 33
Phoenix 33
Chicago 32
Guayaquil 32
Chennai 30
Bắc Ninh 29
Thái Bình 29
Campinas 28
Warsaw 28
Zhengzhou 27
Thái Nguyên 26
San Francisco 25
Buenos Aires 24
London 24
Manaus 23
Wuhan 23
Bogotá 22
Borås 22
Totale 27.432
Salva come PNG Salva come JPEG
Nome #
Anaflatoxin B1 as the Paradigm of a New Class of Vaccines Based on “Mycotoxoids” 305
A transphyletic anti-infectious control strategy based on the killer phenomenon. 288
Novel activity of a synthetic decapeptide against Toxoplasma gondii Tachyzoites 282
Production of an engineered killer peptide in Nicotiana benthamiana by using a Potato virus X expression system 244
Dissecting the structure-function relationship of a fungicidal peptide derived from the constant region of human immunoglobulins 222
Il problema dell’antibiogramma nelle infezioni da funghi filamentosi. 218
Antifungal properties of newly designed carbonic anhydrases inhibitors selective for microbial enzymes 209
A synthetic peptide as a novel anticryptococcal agent 205
Antibodies as a source of anti-infective peptides: an update 201
A Naturally Occurring Antibody Fragment Neutralizes Infectivity of Diverse Infectious Agents 196
Metabolic profiling of Candida albicans 195
Analisi dell’attività fungicida di un peptide derivato dalla regione costante di immunoglobuline M umane 194
AFM1 in Milk: Physical, Biological, and Prophylactic Methods to Mitigate Contamination 188
Activity of a synthetic microbicidal peptide against Influenza A virus multiplication 184
Antifungal activity of the C-terminal peptide from human serum albumin 183
Antibiocorpi: Anticorpi anti-idiotipo ad attività antibiotica in vivo ed in vitro 182
Anticorpi immagini interne di tossine killer 181
Fungicidal activity of peptides encoded by immunoglobulin genes 180
Peptides of the Constant Region of Antibodies Display Fungicidal Activity 177
Antibody Complementarity-Determining Regions (CDRs): A Bridge between Adaptive and Innate Immunity 176
Antifungal peptides within the antibodies 176
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies 175
L’antibiogramma per i miceti 172
Valutazione del sistema Bactec Mycobacterial Growth Indicator Tube (MGIT) 960 per il rilevamento di micobatteri dai materiali patologici in comparazione ai metodi radiometrico e tradizionale 171
Effect of different wavelengths and dyes on Candida albicans: In vivo study using Galleria mellonella as an experimental model 171
Anticorpi antibiotici antiidiotipo immagini interne di tossine killer. 168
Micologia Clinica. Manuale di Laboratorio. 166
Antibody constant region peptides can display immunomodulatory activity through activation of the Dectin-1 signalling pathway. 166
Natural and synthetic peptides with antifungal activity 164
Antimicrobial activity of poultry bone and meat trimmings hydrolyzates in low-sodium turkey food 162
Antibodies as unlimited source of anti-infective, anti-tumor and immunomodulatory peptides 162
Peptides from the inside of the antibodies are active against infectious agents and tumours 162
Anaerobic yeast killer system. 160
Antibody peptide based antifungal immunotherapy 160
Antibody-mediated protective immunity in fungal infections 160
Mode of action of a killer peptide against Toxoplasma gondii 159
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities 158
Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes. 157
Metabolic profile of Candida albicans 154
Caratterizzazione ed isotipizzazione di anticorpi monoclonali murini anti-laminarina con potenziale attività candidacida. 153
ANTIMICROBIAL EFFECT ON CANDIDA ALBICANS BY DIFFERENT COUPLING OF WAVELENGTHS AND COLORS IN PHOTODYNAMIC PROTOCOLS: IN VITRO AND IN VIVO STUDY 152
"Antibiobodies": yeast killer toxin-like anti-idiotypic antibodies 152
Oral and maxillofacial fungal infections 151
Chimeric symbionts expressing a Wolbachia protein stimulate mosquito immunity and inhibit filarial parasite development 151
Therapeutic Activity of an Anti-Idiotypic Antibody-Derived Killer Peptide against Influenza A Virus Experimental Infection 150
AC-1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model 150
Conformation-sensitive Antibodies against Alzheimer Amyloid-beta by Immunization with a Thioredoxin-constrained B-cell Epitope Peptide 149
Antireceptor yeast killer toxin-like antibiobodies 148
Antibiobodies: antibiotic-like antiidiotypic antibodies. 148
Antibiocorpi: anticorpi anti-idiotipo ad attività antibiotica 147
Innate antimicrobial and antiviral activities of antibody peptides 147
Caratterizzazione dell'epitopo polisaccaridico reattivo con IgA secretorie della mannoproteina maggiore da stress secreta da Candida albicans. 147
A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo 146
Selective miRNA down-regulation in the inhibition of HIV-1 replication by a human serum antibody-derived peptide 145
A killer mimotope with therapeutic activity against AIDS-related opportunistic microorganisms inhibits ex vivo HIV-1 replication 145
Vaccination of lactating dairy cows for the prevention of Aflatoxin B1 carry over in milk 144
Yeast killer toxin-like candidacidal Ab6 antibodies elicited through the manipulation of the idiotypic cascade 144
Dissection of the Structural Features of a Fungicidal Antibody-Derived Peptide 144
Antibiobodies: antibiotic internal image antibodies 143
A Multicenter Comparative Evaluation of Six Commercial Systems and the National Committee for Clinical Laboratory Standards M27-A Broth Microdilution Method for Fluconazole Susceptibility Testing of Candida Species 143
Significato diagnostico delle IgA (secretorie) adese a miceti lievitiformi nel corso delle infezioni orali di pazienti a rischio. 143
In vitro activity of killer peptide against Toxoplasma gondii tachyzoites 143
Activity of nitroimidazole derivative synthetic compounds on Trichomonas vaginalis and Candida albicans isolates 139
Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs 139
Anticorpi antiidiotipici ricombinanti ad attività terapeutica fungicida. 139
Attività in vitro e in vivo nei confronti di Candida albicans di peptidi sintetici progettati in silico 138
A multicenter study of the in vitro activity of voriconazole against 1,996 yeast and 192 mould clinical isolates 137
A case of disseminated fatal infection caused by Nocardia caviae. 136
A microautomated dilution method for susceptibility testing with antifungal drugs. 135
Caratterizzazione di mannoproteine da stress di Candida albicans reattive con IgA secretorie 135
Cases of imported malaria in Parma observed in the period January-September 1994 135
Significato diagnostico di IgA secretorie adese a cellule lievitiformi nelle candidosi orali 135
Antibiotic antibodies 133
Development of a novel paratransgenic symbiotic-based control strategy for vector-borne infectious diseases 133
In vitro and in vivo anticandidal activity of killer peptide derivatives 132
Actinomiceti. 131
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis 130
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation 130
A Wickerhamomyces anomalus killer strain in the malaria vector Anopheles stephensi 129
Restriction of Influenza virus multiplication induced by PK peptide treatment 128
Relazione struttura-funzione di un peptide fungicida derivato dalla regione costante di immunoglobuline G umane 128
A novel glyco-conjugate vaccine against fungal pathogens 125
Caratterizzazione antigenica di Microsporum canis, M. distortum, M. ferrugineum e Trichophyton soudanense. 124
Involvement of beta-glucans in the wide-spectrum antimicrobial activity of Williopsis saturnus var. mrakii MUCL 41968 killer toxin 124
In vitro antifungal susceptibility to six antifungal agents of 229 Candida isolates from patients with diabetes mellitus. 124
Marcatori epidemiologici. 123
Idiotypic antifungal vaccination: Immunoprotection by antiidiotypic antibiotic antibodies 123
Any antibody fragment might exert antifungal activity 121
Antibodies as Crypts of Antiinfective and Antitumor Peptides 120
Ogni frammento anticorpale può esplicare attività antinfettiva ed antitumorale. 120
Anti-idiotypic vaccination against group B streptococci 120
Therapeutic potential of yeast killer toxin-like antibodies and mimotopes 119
Inhibition performed by a synthetic microbicidal peptide on the replication of Influenza virus. Abstract 21.009 118
Reversible self-assembly: A key feature for a new class of autodelivering therapeutic peptides 117
Clonaggio e sequenziamento dei geni codificanti per la tossina killer di Pichia anomala 116
Yeast killer toxins and dimorphism. 116
Protective antifungal yeast killer toxin-like antibodies 115
Human natural yeast killer toxin-like antibodies 115
Immagine interna del fenomeno killer dei lieviti 115
Candidacidal properties of peptides encoded by immunoglobulin genes 115
Totale 15.530
Salva come PNG Salva come JPEG
Categoria #
all - tutte 177.195
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 177.195
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.348 0 0 0 50 83 111 333 458 97 285 95 836
2022/20235.790 940 414 267 308 585 607 48 289 2.149 20 111 52
2023/20241.866 105 189 65 53 189 511 50 100 20 133 167 284
2024/20256.781 43 565 563 307 587 571 107 210 1.281 855 464 1.228
2025/202616.219 1.128 1.804 2.195 2.316 2.308 873 1.962 518 1.864 828 281 142
2026/20273.526 787 917 750 1.072 0 0 0 0 0 0 0 0
Totale 49.096